China Resources Double-Crane Pharmaceutical Co Ltd (600062) — Free Cash Flow Generation Index
China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥295.62 Million represents 1% of operating cash flow (CN¥487.90 Million). Read debt load of China Resources Double-Crane Pharmaceuti for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China Resources Double-Crane Pharmaceutical Co Ltd Free Cash Flow Generation Index (1999–2024)
Historical FCF Generation Index trend for China Resources Double-Crane Pharmaceutical Co Ltd across 26 annual periods. Explore China Resources Double-Crane Pharmaceuti capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for China Resources Double-Crane Pharmaceutical Co Ltd (1999–2024)
Year-by-year Free Cash Flow Generation Index for China Resources Double-Crane Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of China Resources Double-Crane Pharmaceuti.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.65x | CN¥1.19 Billion | CN¥1.83 Billion | CN¥637.50 Million | ▲ +4.7% |
| 2023 | 0.62x | CN¥1.03 Billion | CN¥1.65 Billion | CN¥614.31 Million | ▲ +2.2% |
| 2022 | 0.61x | CN¥816.14 Million | CN¥1.34 Billion | CN¥525.53 Million | ▼ -4.0% |
| 2021 | 0.63x | CN¥849.25 Million | CN¥1.34 Billion | CN¥491.67 Million | ▼ -14.9% |
| 2020 | 0.74x | CN¥1.01 Billion | CN¥1.36 Billion | CN¥348.09 Million | ▼ -10.6% |
| 2019 | 0.83x | CN¥1.20 Billion | CN¥1.44 Billion | CN¥241.65 Million | ▼ -1.4% |
| 2018 | 0.84x | CN¥1.24 Billion | CN¥1.47 Billion | CN¥228.69 Million | ▼ -2.9% |
| 2017 | 0.87x | CN¥1.03 Billion | CN¥1.19 Billion | CN¥154.82 Million | ▲ +1.4% |
| 2016 | 0.86x | CN¥661.20 Million | CN¥771.25 Million | CN¥110.04 Million | ▲ +12.8% |
| 2015 | 0.76x | CN¥532.86 Million | CN¥701.35 Million | CN¥168.49 Million | ▼ -5.2% |
| 2014 | 0.80x | CN¥576.00 Million | CN¥718.38 Million | CN¥142.38 Million | ▲ +33.3% |
| 2013 | 0.60x | CN¥328.56 Million | CN¥546.24 Million | CN¥217.68 Million | ▲ +36.8% |
| 2012 | 0.44x | CN¥174.16 Million | CN¥396.05 Million | CN¥221.89 Million | ▲ +30.2% |
| 2011 | 0.34x | CN¥172.74 Million | CN¥511.53 Million | CN¥338.78 Million | ▲ +23.4% |
| 2010 | 0.27x | CN¥139.50 Million | CN¥509.67 Million | CN¥370.18 Million | ▲ +64.6% |
| 2009 | 0.17x | CN¥56.85 Million | CN¥342.01 Million | CN¥285.16 Million | ▲ +145.0% |
| 2008 | 0.07x | CN¥22.51 Million | CN¥331.71 Million | CN¥309.20 Million | ▼ -83.9% |
| 2007 | 0.42x | CN¥99.29 Million | CN¥235.46 Million | CN¥136.17 Million | ▼ -3.0% |
| 2006 | 0.43x | CN¥132.05 Million | CN¥303.71 Million | CN¥171.66 Million | ▲ +380.8% |
| 2005 | 0.09x | CN¥12.64 Million | CN¥139.78 Million | CN¥127.13 Million | ▼ -84.0% |
| 2004 | 0.57x | CN¥256.88 Million | CN¥453.72 Million | CN¥196.84 Million | ▲ +137.1% |
| 2003 | -1.52x | CN¥-227.05 Million | CN¥148.94 Million | CN¥375.98 Million | ▼ -92.5% |
| 2002 | -0.79x | CN¥-111.35 Million | CN¥140.63 Million | CN¥251.99 Million | ▼ -222.9% |
| 2001 | -0.25x | CN¥-34.57 Million | CN¥141.01 Million | CN¥175.58 Million | ▼ -149.3% |
| 2000 | 0.50x | CN¥85.98 Million | CN¥172.81 Million | CN¥86.83 Million | ▲ +6.1% |
| 1999 | 0.47x | CN¥61.67 Million | CN¥131.54 Million | CN¥69.86 Million | — |